Addiction
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|
Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) |
NIH |
10/18/2019 |
11/07/2022 |
|
|
Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed) |
NIH |
04/10/2019 |
07/15/2021 |
|
|
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) |
NIH |
04/23/2019 |
01/07/2022 |
|
|
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) |
NIH |
03/07/2019 |
03/23/2022 |
|
|
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) |
NIH |
03/07/2019 |
03/23/2022 |
|
|
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
NIH |
11/9/2018 |
11/8/2021 |
|
|
Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional) |
NIH |
1/9/2018 |
12/18/2020 |
|
|
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) |
NIH |
11/30/2017 |
11/13/2020 |
|
|
Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) |
NIH |
11/30/2017 |
11/13/2020 |
|
|
Population Assessment of Tobacco and Health (PATH) Biospecimen Access (X01) |
NIH |
8/15/2017 |
7/31/2020 |
|
|
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01) |
NIH |
9/30/2016 |
11/13/2020 |
|
|
Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34) |
NIH |
9/30/2016 |
11/13/2020 |